Pricing Log in Create free account

Nephros Inc. (NEPH) vs NexGel, Inc. (NXGL)

Nephros Inc. and NexGel, Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $33.6M against $12.7M — 2.7× the size. NexGel, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 18.0×. Nephros Inc. grew revenue faster over the last twelve months: 20.4% against 3.38%. Nephros Inc. has the higher net margin (8.86% vs −51.3%) and the higher return on invested capital (14.3% vs −45.3%). Across the 18 metrics below, Nephros Inc. leads on 14 and NexGel, Inc. on 4.

Valuation

Metric NEPH NXGL Medical Instruments & Supplies median
P/E 17.98 n/m 30.28
P/S 1.59 0.15 2.49
P/B 2.74 0.32 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA 15.32 n/m 14.87
EV/Sales 1.38 0.32 2.75
Earnings yield 5.56% (363.17%) 0.00%
Free cash flow yield (3.02%) (189.42%) 0.59%

Profitability

Metric NEPH NXGL Medical Instruments & Supplies median
Gross margin 60.55% 35.08% 53.60%
Operating margin 8.48% (44.77%) 1.97%
Net margin 8.86% (51.26%) 0.00%
Free cash flow margin (4.22%) (27.66%) 2.36%
Return on equity 16.95% (117.57%) 0.00%
Return on assets 13.39% (34.21%) 0.00%
Return on invested capital 14.29% (45.29%) 0.13%

Growth

Metric NEPH NXGL Medical Instruments & Supplies median
Revenue growth (TTM) 20.36% 3.38% 8.97%
EPS growth (last fiscal year) 1,471.43% 24.00% 6.51%
Revenue growth, 5-year CAGR 17.02% 76.12% 8.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEPH NXGL Medical Instruments & Supplies median
Debt to equity 0.00 0.68 0.10
Current ratio 5.50 0.43 2.47
Net debt to EBITDA (4.20) 0.13 0.97

Dividend

Metric NEPH NXGL Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric NEPH NXGL Medical Instruments & Supplies median
Market cap 33.59m 12.65m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack